Jing-Jing Wang1, Walana Williams1, Bing Wang1, Jing Wei1, Xia Lu2, Jya-Wei Cheng3, John R Gordon4, Jing-Min Li2, Fang Li1. 1. Department of Immunology, Dalian Medical University, Dalian 116044, Liaoning Province, China. 2. Department of Ophthalmology, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, Liaoning Province, China. 3. Institute of Biotechnology, Department of Life Science, Tsing Hua University, Hsinchu 300, Taiwan, China. 4. The Division of Respirology, Critical Care and Sleep Medicine, Royal University Hospital, University of Saskatchewan, Saskatoon S7N 5A2, Canada.
Abstract
AIM: To investigate the effect of interleukin-8 (IL-8) on neural retinal ganglion cells (RGCs) and whether it can be alleviated by G31P. METHODS: RGC-5 cells were exposed to IL-8 with or without its specific receptor antagonist G31P for 24h, and the cell viability was assessed by Cell Counting Kit 8 (CCK-8). Apoptosis was measured by examining nuclear morphology and quantifying with flow cytometry. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) and Western blot were used to investigate the expression of apoptosis-related genes. RESULTS: CCK-8 assay showed that IL-8 significantly inhibits the viability of RGC-5 cells in a dose-dependent manner. Cell apoptosis assays exhibited higher apoptotic rate in IL-8 treatment group compared to control group. We further found that IL-8 could promote Bax and caspase-3 expressions, but decrease the level of Bcl-2 in the aspect of mRNA and protein. However, pre-treatment with G31P partly attenuated these effects in RGC-5 cells (P<0.05). CONCLUSION: These results indicate that anti-proliferation effects of IL-8 through induction of cell apoptosis regulated by Bcl-2, Bax and caspase-3 expressions, can be ameliorated by G31P.
AIM: To investigate the effect of interleukin-8 (IL-8) on neural retinal ganglion cells (RGCs) and whether it can be alleviated by G31P. METHODS: RGC-5 cells were exposed to IL-8 with or without its specific receptor antagonist G31P for 24h, and the cell viability was assessed by Cell Counting Kit 8 (CCK-8). Apoptosis was measured by examining nuclear morphology and quantifying with flow cytometry. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) and Western blot were used to investigate the expression of apoptosis-related genes. RESULTS: CCK-8 assay showed that IL-8 significantly inhibits the viability of RGC-5 cells in a dose-dependent manner. Cell apoptosis assays exhibited higher apoptotic rate in IL-8 treatment group compared to control group. We further found that IL-8 could promote Bax and caspase-3 expressions, but decrease the level of Bcl-2 in the aspect of mRNA and protein. However, pre-treatment with G31P partly attenuated these effects in RGC-5 cells (P<0.05). CONCLUSION: These results indicate that anti-proliferation effects of IL-8 through induction of cell apoptosis regulated by Bcl-2, Bax and caspase-3 expressions, can be ameliorated by G31P.
Authors: Xixing Zhao; Jennifer R Town; Fang Li; Xiaobei Zhang; Donald W Cockcroft; John R Gordon Journal: J Immunol Date: 2009-03-01 Impact factor: 5.422
Authors: Marcus Karlstetter; Rebecca Scholz; Matt Rutar; Wai T Wong; Jan M Provis; Thomas Langmann Journal: Prog Retin Eye Res Date: 2014-12-02 Impact factor: 21.198
Authors: John Kuchtey; Kasra A Rezaei; Pimkwan Jaru-Ampornpan; Paul Sternberg; Rachel W Kuchtey Journal: Invest Ophthalmol Vis Sci Date: 2010-06-30 Impact factor: 4.799
Authors: Maria C Sánchez-Migallón; Francisco J Valiente-Soriano; Francisco M Nadal-Nicolás; Manuel Vidal-Sanz; Marta Agudo-Barriuso Journal: Invest Ophthalmol Vis Sci Date: 2016-01-01 Impact factor: 4.799
Authors: L F Lue; R Rydel; E F Brigham; L B Yang; H Hampel; G M Murphy; L Brachova; S D Yan; D G Walker; Y Shen; J Rogers Journal: Glia Date: 2001-07 Impact factor: 7.452
Authors: Jens Lutz; Le A Luong; Matthias Strobl; Meihong Deng; Hai Huang; Martina Anton; Mustafa Zakkar; Karine Enesa; Hera Chaudhury; Dorian O Haskard; Marcus Baumann; Joseph Boyle; Sarah Harten; Patrick H Maxwell; Charles Pusey; Uwe Heemann; Paul C Evans Journal: J Mol Med (Berl) Date: 2008-09-24 Impact factor: 4.599
Authors: Michaël J A Girard; Meghna R Beotra; Khai Sing Chin; Amanjeet Sandhu; Monica Clemo; Eleni Nikita; Deborah S Kamal; Maria Papadopoulos; Jean Martial Mari; Tin Aung; Nicholas G Strouthidis Journal: Ophthalmology Date: 2016-03-16 Impact factor: 12.079